HSIC vs OPY · P/E 24, rev $12.67B vs P/E 13, rev $1.43B
Henry Schein Inc (HSIC) versus Oppenheimer Holdings Inc (OPY) — a side-by-side from cached financials, not a winner call.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
Oppenheimer Holdings Inc (OPY) is a capital markets company listed on NYSE.
Latest reported HSIC revenue for 2024-12-28 was $12.67B. Net income was $398.0M. Revenue was up 2.7% from 2023-12-30 to 2024-12-28. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
Latest reported OPY revenue for 2024-12-31 was $1.43B. Net income was $71.2M. Revenue was up 14.7% from 2023-12-31 to 2024-12-31. OPY currently screens at market cap $1.15B and trailing P/E 12.8.
HSIC currently screens at market cap $9.11B and trailing P/E 24.2. OPY currently screens at market cap $1.15B and trailing P/E 12.8.
Not investment advice. Open the HSIC and OPY stock pages for the full models.
Not investment advice.